Alabama Dispenses First Medical Cannabis to Cullman Patient

First Legal Sale Ends Five-Year Wait

A Cullman woman became the first Alabama patient to legally purchase medical cannabis on June 3, ending a five-year implementation period that began with legislative authorization in 2021. The sale happened at a licensed dispensary in Cullman, according to WVTM reporting. The Alabama Medical Cannabis Commission (AMCC) hasn't released the patient's name or the dispensary location.

Alabama Governor Kay Ivey signed the Darren Wesley 'Ato' Hall Compassion Act into law on May 17, 2021. The statute, SB 46, established a vertically integrated medical cannabis framework with state-issued cultivation, processing, dispensary, and testing licenses.

Program Timeline: From Statute to Sale

The five-year gap between authorization and first sale reflects Alabama's cautious regulatory buildout. Key milestones include:

• May 2021: SB 46 signed into law, establishing the AMCC and patient registry.
• 2022-2023: AMCC rulemaking, license application windows, and background reviews.
• 2024: First cultivation licenses awarded; grow facilities under construction.
• 2025: Harvests begin; processor and dispensary licenses finalized.
• June 3, 2026: First legal patient sale.

Alabama's timeline ranks among the slowest medical cannabis rollouts in the U.S., comparable to Louisiana's seven-year implementation.

Qualifying Conditions and Patient Access

Alabama's program covers 16 qualifying conditions, including cancer, epilepsy, PTSD, chronic pain, and Crohn's disease. Patients must obtain a recommendation from a state-licensed physician registered with the AMCC. No physical cards. Patients receive a digital certification linked to a state database accessible by dispensaries.

As of June 2026, the AMCC hasn't published patient enrollment figures. Early projections from 2021 estimated 50,000 to 100,000 eligible patients statewide, though actual uptake will depend on physician participation and dispensary density.

Licensed Operator Landscape

The AMCC awarded five vertically integrated licenses and approximately a dozen standalone dispensary licenses. Cultivators include Alabama Always, Grow Alabama, and State Grown Alabama. Dispensary operators include Releaf Alabama and Southern Roots, though the commission hasn't published a complete public registry of active locations.

The Cullman dispensary's identity remains unconfirmed. Cullman County, population 88,000, sits in north-central Alabama approximately 50 miles north of Birmingham. The county's rural character and conservative voting history make it a notable first-sale location.

Product Availability and Pricing

Alabama statute restricts medical cannabis to non-smokable forms: tablets, capsules, tinctures, topicals, suppositories, transdermal patches, nebulizers, and oils for vaporization. Raw flower and edibles remain prohibited. Vaporizable oils must be used in devices approved by the AMCC.

Pricing data isn't yet available. Comparable Southern medical programs—Louisiana, Arkansas, Mississippi—report average patient costs of $300 to $500 per month for chronic-condition regimens, and Alabama's vertically integrated license structure may compress margins but also limits competition.

What Comes Next

The first sale triggers a 90-day monitoring window during which the AMCC will track adverse events, diversion reports, and dispensary compliance. Additional dispensaries are expected to open in Birmingham, Montgomery, Mobile, and Huntsville by July 2026. The commission has signaled it may open a second license application round in 2027 if patient demand exceeds current capacity.

For full background on this story, see the CannIntel topic hub on Alabama Medical Cannabis Program.

Physician enrollment rates will be critical. Alabama's conservative medical community has historically been skeptical of cannabis therapeutics, and the program's success hinges on primary-care and specialist participation.